Technology

April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol succinate extended-release tablets. The beta-blocker is used to treat angina, heart failure and high blood pressure.

Home April 18, 2010
Home
Technology

April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to provide protection against infections. The AigisRx Flat delivers the antimicrobial agents rifampin and minocycline.

Home April 14, 2010
Home
News

April 14, 2010 – Two external pacemakers were launched in Europe today that offer an intuitive design for safer usage in emergencies and temporary patient care.

Home April 14, 2010
Home
News

April 14, 2010 – The Mount Sinai Medical Center in New York has become the first facility in the United States to commercially use a new cardiac nuclear imaging system that drastically reduces imaging time and radiation exposure.

Home April 14, 2010
Home
News

April 14, 2010 - When college football’s elite enter Radio City Music Hall April 22 for the 2010 National Football League (NFL) draft, it will be after much public analysis of their stats and accomplishments. Also important to a player’s prospect of being drafted is the outcome of diagnostic tests including X-rays, magnetic resonance imaging (MRI) and cardiac evaluations.

Home April 14, 2010
Home
Technology

April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter and ambulatory blood pressure monitoring recorder and software analysis system.

Home April 13, 2010
Home
Technology

April 13, 2010 – A catheter designed to deliver embolic materials and radiopaque media to selected sites in visceral vascular territories recently gained FDA clearance. The Gandras Visci-G is a 5 French, 75 cm catheter with a primary curve and a flexible 1 cm tip, making it useful for precise and stable placement in renal, mesenteric or abdominal catheterization procedures.

Home April 13, 2010
Home
News

April 13, 2010 – More than 300 patients in Europe have been enrolled in a real-world study to assess the effectiveness of a coronary bifurcation stent. Enrollment was completed last week in E-Tryton 150 and E-Tryton Benelux, two European registry studies evaluating the Tryton Side Branch Stent System for the treatment of atherosclerotic lesions in the side branch at the site of a bifurcation.

Home April 13, 2010
Home
Feature

April 13, 2010 – Obstructive sleep apnea is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from a landmark study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.

Home April 13, 2010
Home
News

April 9, 2010 – The first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system to treat abdominal aortic aneurisms (AAA).

Home April 09, 2010
Home
News

April 9, 2010 – A survey of physicians by Majestic Research found that Boston Scientific’s March 15 decision to withdraw from the implantable cardioverter defibrillator (ICD) market will have a meaningful, long-term impact on the implantable electrophysiology device market.

Home April 09, 2010
Home
News

April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce atherosclerosis in mice.

Home April 08, 2010
Home
News

April 7, 2010 – A medical manufacturer pleaded guilty Monday to criminal violations for improper reporting of short-circuit failures of three models of its implantable cardioverter defibrillators (ICDs), the Justice Department announced. The company also agreed to pay more than $296 million in damages.

Home April 07, 2010
Home
News

April 7, 2010 – The U.S. Food and Drug Administration (FDA) recently sent a warning letter to Edwards Lifesciences Corp. for late reporting of adverse events with its medical devices.

Home April 07, 2010
Home
News

April 7, 2010 – A study concludes ventilator efficiency (VE/VCO2 slope) is more accurate than the current listing criteria for heart transplantation in identifying patients likely to derive a survival benefit from such intervention. The results were recently published in Circulation Heart Failure, a journal of the American Heart Association.

Home April 07, 2010
Home
Subscribe Now